Partner, Playground Global
Bioengineering PhD backing engineered biology companies
Benjamin Kim is a Partner at Playground Global who joined as a Venture Fellow in 2019 while completing his PhD in bioengineering at Stanford University, where he was a National Science Foundation Fellow. He focuses on identifying founders revolutionizing engineered biology, emerging modality therapeutics, and AI-driven drug development workflows. He led Playground's investments in Atomic AI, Infinimmune, Manifold Bio, Outpace Bio, and Insamo.
Invest in companies revolutionizing engineered biology and applying AI/ML to refactor drug development.
Based in: Palo Alto, CA (North America)